Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 15.0B | 14.9B | 14.7B | 14.1B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 6.3B | 6.5B | 6.9B | 6.1B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 12.0B | 3.3B | 4.0B | 423M |
Tax provision | 985M | 698M | 534M | 794M |
Net income | 11.1B | 2.8B | 3.6B | -181M |
Basic EPS | 6.3 | 1.6 | — | -0.1 |
Diluted EPS | 6.3 | 1.6 | — | -0.1 |
Basic average shares | 1.7B | 1.7B | — | 1.7B |
Diluted average shares | 1.7B | 1.8B | — | 1.7B |
EBITDA | — | — | — | — |
Net income from continuing op. | 11.1B | 2.8B | 3.6B | -181M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |